MRCG-HRB Joint Funding Scheme

 

NOW CLOSED

INCREASING SURVIVAL OF PATIENTS WITH POOR PROGNOSIS CANCERS

 

Opening Date:  17th October 2017

Closing Date:    30th November 2017 (5pm GMT)

 

Introduction:

Breakthrough Cancer Research (Breakthrough) is an Irish Medical Cancer Research Charity focused on funding research leading to new treatments for cancers which do not respond or are poorly served by available treatments. Breakthrough is committed to funding research to improve cancer care and outcomes and we ensure patient benefit is at the core of our efforts.  We emphasise clinically engaged projects, the role of the immune system and look for new interventions or approaches throughout the patient journey which will positively impact survival of patients with the toughest to cure cancers. 

 

Application Requirements:

Breakthrough invite research applications which:

  • Are patient focused and respond to a clinical need
  • Can demonstrate a path to translation into an intervention/treatment
  • Align with our Strategic Research Priorities

 

Funding Available:

Funding of up to €300,000 will be provided, for projects from 12 up to 36 months.  

 

Important Dates

30th November 2017 (5pm)

Deadline for Submission of Proposals to Breakthrough Cancer Research

November 2017 – January 2018

Charity Peer Review

Early-Mid February 2018

Right to Reply Phase

9th April 2018

HRB Application Deadline

July 2018

Applicant Notification

September 2018

Research Project Start

 

Application Procedure

All applications must be submitted by email to research@breakthroughcancerresearch.ie by 30th November 2017, 5pm GMT.

 

Further Information

For further information on MRCG-HRB Joint Funding Scheme go to:

or contact Orla Dolan via email on research@breakthroughcancerresearch.ie 

 

Related Documents to Download

© Site Designed by Granite Digital